TGFBR1 and epilepsy: Notably, blocking TGF-β signaling with Alk5 inhibitors SJN2511 or SB431542, or with angiotensin receptor 2 antagonist losartan, prevents the albumin-initiated gene response and epilepsy [69,314,316,318,319].